ICD-10-CM Billable Code

B02.39

Other herpes zoster eye disease

Clinical Classification Guidelines

Inclusion Terms

  • Zoster blepharitis

Medical Intelligence & Overview

Herpes zoster eye disease, classified under ICD-10 code B02.39, refers to herpetic infections affecting the eye and surrounding structures. This condition is caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox and shingles. When the virus reactivates, it can involve the eye, leading to a variety of ocular complications. Herpes zoster eye disease, including zoster blepharitis, can cause discomfort, visual disturbances, and in some cases, long-term damage if not properly managed. Understanding the causes, symptoms, diagnosis, and treatment options can help in managing this condition effectively.

Causes & Symptoms

Clinical Causes: Reactivation of the varicella-zoster virus in individuals who have previously had chickenpox. A weakened immune system which can allow the virus to reactivate. Aging, as older adults are more susceptible to herpes zoster infections. Stress or other illnesses that suppress immune function. Localized skin involvement on the face or eyelids, which can extend to the eye area.

Key Symptoms: Pain, burning, or tingling sensation in the affected area. Redness and swelling around the eye or eyelids. Herpetic skin lesions or blisters near the eye, possibly on the eyelid (zoster blepharitis). Sensitivity to light (photophobia). Blurred or decreased vision. Lacrimation or excessive tearing. Fever or malaise in some cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of herpes zoster eye disease involves a thorough clinical evaluation by a healthcare professional, including detailed history-taking of prior herpes zoster episodes or shingles. Physical examination may reveal characteristic skin lesions and signs of ocular involvement. Eye-specific tests, such as slit-lamp examination, can identify inflammation of the eyelid or cornea. In ambiguous cases, laboratory tests like PCR or direct fluorescent antibody testing may be utilized to detect the presence of the varicella-zoster virus. Early recognition and diagnosis are vital to prevent possible complications such as vision loss or corneal scarring.

Treatment Protocols: Treatment focuses on reducing symptoms, controlling the viral infection, and preventing complications. Common interventions include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B02.39 a billable ICD-10 code?
Yes, B02.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B02.39?
Clinical documentation must specify the nature of Other herpes zoster eye disease and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

disease herpes zoster